Related references
Note: Only part of the references are listed.Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
Steven R. Cummings et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
Athanasios D. Anastasilakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Assessment of the Effects of Age and Renal Function on Pharmacokinetics of Bazedoxifene in Postmenopausal Women
William McKeand et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Pharmacokinetics and Safety of Bazedoxifene in Hepatically Impaired and Healthy Postmenopausal Women
William McKeand et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Evaluation of the first fracture liaison service in the Greek healthcare setting
Polyzois Makras et al.
ARCHIVES OF OSTEOPOROSIS (2017)
Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment
Athanasios D. Anastasilakis et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
Athanasios D. Anastasilakis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis A systematic review and meta-analysis
Lihua Peng et al.
MEDICINE (2017)
Efficacy and safety of bazedoxifene in postmenopausal Latino women with osteoporosis
Jose A. Hernandez Bueno et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2017)
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS
Elena Tsourdi et al.
BONE (2017)
Pharmacokinetics, Dose Proportionality, and Bioavailability of Bazedoxifene in Healthy Postmenopausal Women
William McKeand
CLINICAL THERAPEUTICS (2017)
Vertebral Fractures: Clinical Importance and Management
D. L. Kendler et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Efficacy and tolerability of bazedoxifene in Mexican women with osteoporosis: a subgroup analysis of a randomized phase 3 trial
Santiago Palacios et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2016)
The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis
Thomas J. Beck et al.
BONE (2015)
A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture
Santiago Palacios et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)
Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
Dae Hyun Kim et al.
PLOS ONE (2015)
Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women
Alexandra G. Ellis et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
Nicole C. Wright et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
Joann V. Pinkerton et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Evaluation of the Efficacy and Safety of Bazedoxifene/Conjugated Estrogens for Secondary Outcomes Including Vasomotor Symptoms in Postmenopausal Women by Years Since Menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) Trials
JoAnn V. Pinkerton et al.
JOURNAL OF WOMENS HEALTH (2014)
Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture: A Network Meta-Analysis
Alexandra G. Ellis et al.
VALUE IN HEALTH (2014)
A Double-Blind, Randomized, Ascending, Multiple-Dose Study of Bazedoxifene in Healthy Postmenopausal Women
William E. McKeand et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2014)
Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women
S. Mirkin et al.
CLIMACTERIC (2013)
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis
Nelson Watts et al.
Endocrine Practice (2013)
Breast Effects of Bazedoxifene-Conjugated Estrogens A Randomized Controlled Trial
JoAnn V. Pinkerton et al.
OBSTETRICS AND GYNECOLOGY (2013)
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
J. A. Kanis et al.
OSTEOPOROSIS INTERNATIONAL (2013)
An evaluation of the Fracture Risk Assessment Tool (FRAX®) as an indicator of treatment efficacy: the effects of bazedoxifene and raloxifene on vertebral, nonvertebral, and all clinical fractures as a function of baseline fracture risk assessed by FRAX®
J. -M. Kaufman et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Osteoporosis in the European Union: a compendium of country-specific reports
A. Svedbom et al.
ARCHIVES OF OSTEOPOROSIS (2013)
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
Josep Darba et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2013)
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Philipp Y. Maximov et al.
CURRENT CLINICAL PHARMACOLOGY (2013)
Bisphosphonates for Osteoporosis - Where Do We Go from Here?
Marcea Whitaker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study
S. L. Silverman et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab
Athanasios D. Anastasilakis et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2012)
Aging and bone loss: new insights for the clinician
Oddom Demontiero et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
Effects of Bazedoxifene on Bone Mineral Density, Bone Turnover, and Safety in Postmenopausal Japanese Women With Osteoporosis
Akira Itabashi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
Henry G. Bone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trial
Gloria Bachmann et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2011)
Efficacy and safety of bazedoxifene in postmenopausal Asian women
L. Xu et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial
T. J. de Villiers et al.
OSTEOPOROSIS INTERNATIONAL (2011)
SERMs in the prevention and treatment of postmenopausal osteoporosis: an update
Jaime Kulak Junior et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2010)
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis
Claus Christiansen et al.
BMC MUSCULOSKELETAL DISORDERS (2010)
In Vitro Metabolism, Permeability, and Efflux of Bazedoxifene in Humans
Li Shen et al.
DRUG METABOLISM AND DISPOSITION (2010)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women
Risa Kagan et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2010)
Lasofoxifene in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis
P. Makras et al.
BONE (2009)
Metabolic Disposition of [14C]Bazedoxifene in Healthy Postmenopausal Women
Appavu Chandrasekaran et al.
DRUG METABOLISM AND DISPOSITION (2009)
Effects of Various Selective Estrogen Receptor Modulators with or without Conjugated Estrogens on Mouse Mammary Gland
Bryan J. Peano et al.
ENDOCRINOLOGY (2009)
Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis
Annie W. C. Kung et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy
James H. Pickar et al.
FERTILITY AND STERILITY (2009)
Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
Benjamin Z. Leder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women
David F. Archer et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis
JoAnn V. Pinkerton et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2009)
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis
Rene Rizzoli et al.
BONE (2008)
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
Stuart L. Silverman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Selection of antiresorptive or anabolic treatments for postmenopausal osteoporosis
Socrates Papapoulos et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study
Paul D. Miller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis
S. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Update on osteoporosis management in long-term care: Focus on bisphosphonates
Hosam K. Kamel
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2007)
Osteoporosis: A still increasing prevalence
JY Reginster et al.
BONE (2006)
Pathophysiology of age-related bone loss and osteoporosis
S Khosla et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
Safety assessment of raloxifene over eight years in a clinical trial setting
S Martino et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Bazedoxifene acetate: A selective estrogen receptor modulator with improved selectivity
BS Komm et al.
ENDOCRINOLOGY (2005)
Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women
S Ronkin et al.
OBSTETRICS AND GYNECOLOGY (2005)
Continuing outcomes relevant to evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
S Martino et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Pharmacokinetics of selective estrogen receptor modulators
KC Morello et al.
CLINICAL PHARMACOKINETICS (2003)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women
SM Ott et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens
CP Miller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Share Paper
